Reata Pharmaceuticals, Inc. (RETA) Files An 8-K Results of Operations and Financial Condition
Item 2.02.Results of Operations and Financial Condition.
On November 14, 2016, Reata Pharmaceuticals, Inc. (the Company)
issued a press release announcing its financial results for the
three and nine months ended September 30, 2016 (the Press
Release). A copy of the Press Release is furnished herewith as
Exhibit 99.1.
The information set forth under Item 2.02 and in Exhibit 99.1
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any filing under the Securities Act
of 1933, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01.Financial Statements and Exhibits.
|
Exhibit Number |
Description |
|
99.1* |
Press Release, dated November 14, 2016 |
|
* |
Furnished herewith. |
About Reata Pharmaceuticals, Inc. (RETA)
